JP2015537212A5 - - Google Patents

Download PDF

Info

Publication number
JP2015537212A5
JP2015537212A5 JP2015542849A JP2015542849A JP2015537212A5 JP 2015537212 A5 JP2015537212 A5 JP 2015537212A5 JP 2015542849 A JP2015542849 A JP 2015542849A JP 2015542849 A JP2015542849 A JP 2015542849A JP 2015537212 A5 JP2015537212 A5 JP 2015537212A5
Authority
JP
Japan
Prior art keywords
gradient
polypeptide
contaminants
ionic strength
chromatography material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015542849A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015537212A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/070415 external-priority patent/WO2014078729A1/en
Publication of JP2015537212A publication Critical patent/JP2015537212A/ja
Publication of JP2015537212A5 publication Critical patent/JP2015537212A5/ja
Pending legal-status Critical Current

Links

JP2015542849A 2012-11-15 2013-11-15 イオン強度媒介のｐｈ勾配イオン交換クロマトグラフィー Pending JP2015537212A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261727051P 2012-11-15 2012-11-15
US61/727,051 2012-11-15
US201361780707P 2013-03-13 2013-03-13
US61/780,707 2013-03-13
PCT/US2013/070415 WO2014078729A1 (en) 2012-11-15 2013-11-15 IONIC STRENGTH-MEDIATED pH GRADIENT ION EXCHANGE CHROMATOGRAPHY

Publications (2)

Publication Number Publication Date
JP2015537212A JP2015537212A (ja) 2015-12-24
JP2015537212A5 true JP2015537212A5 (OSRAM) 2016-12-28

Family

ID=50731733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015542849A Pending JP2015537212A (ja) 2012-11-15 2013-11-15 イオン強度媒介のｐｈ勾配イオン交換クロマトグラフィー

Country Status (11)

Country Link
US (2) US9810670B2 (OSRAM)
EP (1) EP2920586A4 (OSRAM)
JP (1) JP2015537212A (OSRAM)
KR (1) KR20150084046A (OSRAM)
CN (1) CN105051528A (OSRAM)
BR (1) BR112015011011A2 (OSRAM)
CA (1) CA2890979A1 (OSRAM)
HK (1) HK1217232A1 (OSRAM)
MX (1) MX2015006149A (OSRAM)
RU (1) RU2015122726A (OSRAM)
WO (1) WO2014078729A1 (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015011011A2 (pt) 2012-11-15 2019-12-17 Genentech Inc cromatografia por troca de íon com gradiente de ph mediada por força iônica
RU2016104542A (ru) 2013-07-12 2017-08-17 Дженентек, Инк. Осуществление оптимизации входных условий ионообменной хроматографии
WO2016164708A1 (en) 2015-04-10 2016-10-13 Adimab, Llc Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody species
GB2539420B (en) * 2015-06-16 2021-01-13 Cytiva Sweden Ab Determination of chromatography conditions
EP3377513A1 (en) * 2015-11-18 2018-09-26 Merck Patent GmbH Improved protein separation in ion exchange chromatography
CA3005484A1 (en) * 2015-11-18 2017-05-26 Merck Patent Gmbh Opposite ph-salt gradients for improved protein separations
CN108333264A (zh) * 2017-01-20 2018-07-27 湖北生物医药产业技术研究院有限公司 检测蛋白电荷变异体的方法及确定生物制品生产工艺的方法
US20190126241A1 (en) * 2017-09-26 2019-05-02 Waters Technologies Corporation High purity chromatographic materials comprising an ionizable modifier for retention of acidic analytes
CN112105927B (zh) * 2018-05-08 2024-06-25 沃特世科技公司 可用于pH梯度阳离子交换色谱法的方法、组合物和试剂盒
KR20200080748A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 음이온 교환 크로마토그래피를 이용한 인슐린 전구체의 정제방법
TW202128264A (zh) * 2019-09-25 2021-08-01 瑞士商赫孚孟拉羅股份公司 使用經預測之溶離緩衝鹽濃度的陽離子層析法
CN111024883B (zh) * 2019-12-31 2022-12-06 上海博威生物医药有限公司 一种奥马珠单抗的电荷异质体的分离方法
CN111239278B (zh) * 2020-02-05 2022-11-04 康立泰生物医药(青岛)有限公司 一种检测重组人白介素-12蛋白电荷变异体的方法及应用
JP7686180B2 (ja) * 2020-04-17 2025-06-02 小野薬品工業株式会社 タンパク質製剤原薬の着色除去方法
KR102283871B1 (ko) * 2021-03-02 2021-08-02 한국원자력연구원 크로마토그래피를 이용한 무담체 홀뮴-166의 분리 방법, 분리 장치 및 이에 의하여 분리된 무담체 홀뮴-166
CA3226049A1 (en) * 2021-07-13 2023-01-19 Regeneron Pharmaceuticals, Inc. Characterization of proteins by anion-exchange chromatography mass spectrometry (aex-ms)
WO2023107510A1 (en) * 2021-12-06 2023-06-15 Staveness Daryl Exciplex-based methods for contaminant and disease detection and methods for use of extraction buffers
CN114544839B (zh) * 2022-01-20 2024-08-20 未名生物医药有限公司 一种抗人神经生长因子抗体的电荷变异体检测方法
AU2023409836A1 (en) * 2022-12-20 2025-07-03 Seqirus Inc. Lipid nanoparticle composition
WO2024261724A1 (en) * 2023-06-23 2024-12-26 Lupin Limited Ion-exchange chromatography for separation and analysis of charge variants
WO2025038736A1 (en) * 2023-08-15 2025-02-20 Gigagen, Inc. Methods of analyzing recombinant polyclonal proteins

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
ES2058199T3 (es) 1987-09-23 1994-11-01 Bristol Myers Squibb Co Heteroconjugados de anticuerpos para la eliminacion de celulas infectadas por el vih.
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
DE69029036T2 (de) 1989-06-29 1997-05-22 Medarex Inc Bispezifische reagenzien für die aids-therapie
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5356788A (en) * 1990-03-14 1994-10-18 Her Majesty The Queen In Right Of Canada, As Represented By The National Research Council Of Canada Isolation, quantitation and purification of insecticidal proteins from Bacillus thuringiensis
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
EP0586505A1 (en) 1991-05-14 1994-03-16 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
EP0940468A1 (en) 1991-06-14 1999-09-08 Genentech, Inc. Humanized antibody variable domain
MX9204374A (es) 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
FI941572A7 (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenete lmä
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
EP0617706B1 (en) 1991-11-25 2001-10-17 Enzon, Inc. Multivalent antigen-binding proteins
DE69334255D1 (de) 1992-02-06 2009-02-12 Novartis Vaccines & Diagnostic Marker für Krebs und biosynthetisches Bindeprotein dafür
JP3571337B2 (ja) 1992-02-11 2004-09-29 セル ジェネシス，インコーポレーテッド 遺伝子標的現象による同型遺伝子接合
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
JPH08500017A (ja) 1992-08-17 1996-01-09 ジェネンテク，インコーポレイテッド 二特異的免疫アドヘジン
DE69303494T2 (de) 1992-11-13 1997-01-16 Idec Pharma Corp Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5712374A (en) 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
WO2000055203A1 (en) * 1999-03-15 2000-09-21 Novo Nordisk A/S Ion exchange chromatographic separation of glp-1 and related peptides
AU2002226095A1 (en) * 2000-12-13 2002-06-24 Wackvom Limited Compositions containing an active fraction isolated from tricholoma conglobatum and methods of use
ES2376454T3 (es) 2000-12-22 2012-03-14 Grad, Carole, Legal Representative Of Howard, Kaplan Librer�?as de expresión en fago de fragmentos vh humanos.
US20030031627A1 (en) * 2001-07-31 2003-02-13 Mallinckrodt Inc. Internal image antibodies for optical imaging and therapy
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
CA2516518A1 (en) * 2003-02-28 2004-09-10 Lonza Biologics Plc. Antibody purification by protein a and ion exchange chromatography
DE602004017726D1 (de) 2003-06-30 2008-12-24 Domantis Ltd Pegylierte Single-domain-antikörper (dAb)
SE0303532D0 (sv) * 2003-12-23 2003-12-23 Amersham Biosciences Ab Purification of immunoglobulins
CN101023101A (zh) * 2004-07-20 2007-08-22 西福根有限公司 抗－恒河猴d重组多克隆抗体和生产方法
US20060067930A1 (en) 2004-08-19 2006-03-30 Genentech, Inc. Polypeptide variants with altered effector function
AU2005282700A1 (en) 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
CN101065151B (zh) 2004-09-23 2014-12-10 健泰科生物技术公司 半胱氨酸改造的抗体和偶联物
US20060240564A1 (en) * 2005-04-20 2006-10-26 Chia-Hui Shieh pH gradient ion exchange LC-MS and mass compatible buffers
EP1963367A4 (en) * 2005-12-06 2009-05-13 Amgen Inc POLISHING STEPS IN MULTI-STAGE PROTEIN PURIFICATION TREATMENTS
CN100506983C (zh) * 2006-05-25 2009-07-01 齐鲁制药有限公司 一种从矛头蝮蛇毒中提取单一成份巴曲酶的方法
EP2069387A4 (en) * 2006-06-14 2011-02-02 Glaxosmithkline Llc METHODS OF PURIFYING ANTIBODIES USING HYDROXYAPATITE CERAMIC
KR20100124727A (ko) * 2008-02-29 2010-11-29 세키스이 메디칼 가부시키가이샤 고분자량 아디포넥틴의 측정 방법
MX2012000841A (es) * 2009-07-24 2012-02-28 Hoffmann La Roche Optimizacion de la produccion de anticuerpos.
EP2480561B1 (en) 2009-09-23 2016-07-13 E. R. Squibb & Sons, L.L.C. Cation exchange chromatography
WO2012084829A1 (en) 2010-12-21 2012-06-28 F. Hoffmann-La Roche Ag Isoform enriched antibody preparation and method for obtaining it
BR112013019975A2 (pt) 2011-02-28 2017-08-01 Hoffmann La Roche proteínas de ligação de antígeno, composição farmacêutica, uso de uma proteína de ligação de antígeno, método para o tratamento de um paciente e método para a preparação de uma proteína de ligação de antígeno, ácido nucleico, vetor e célula hospedeira"
WO2013122834A1 (en) * 2012-02-14 2013-08-22 Bio-Rad Laboratories, Inc. REDUCING pH EXCURSIONS IN ION EXCHANGE CHROMATOGRAPHY
BR112015011011A2 (pt) 2012-11-15 2019-12-17 Genentech Inc cromatografia por troca de íon com gradiente de ph mediada por força iônica

Similar Documents

Publication Publication Date Title
JP2015537212A5 (OSRAM)
RU2015122726A (ru) ОПОСРЕДОВАННАЯ ИОННОЙ СИЛОЙ рН-ГРАДИЕНТНАЯ ИОНООБМЕННАЯ ХРОМАТОГРАФИЯ
US10053489B2 (en) Method for purifying antibody
JP2018510867A5 (OSRAM)
Bracewell et al. Re-use of protein A resin: fouling and economics
Maria et al. Purification process of recombinant monoclonal antibodies with mixed mode chromatography
JP2017517745A5 (OSRAM)
Hou et al. Advective hydrogel membrane chromatography for monoclonal antibody purification in bioprocessing
RU2016137932A (ru) In vitro прогнозирование времени полужизни антител in vivo
NZ714079A (en) Purification process for monoclonal antibodies
RU2016112549A (ru) Способ для повторного использования хроматографии
JP2016529489A5 (OSRAM)
HRP20192217T1 (hr) ULTRA-PROČIŠĆENI DsbA I DsbC TE POSTUPCI NJIHOVE IZRADE I UPORABE
JP2016530533A5 (OSRAM)
US20160289264A1 (en) Method for purifying recombinant protein
RU2018121657A (ru) ПРОТИВОПОЛОЖНЫЕ ГРАДИЕНТЫ pH-СОЛЬ ДЛЯ УЛУЧШЕННОГО РАЗДЕЛЕНИЯ БЕЛКОВ
RU2016104542A (ru) Осуществление оптимизации входных условий ионообменной хроматографии
Holstein et al. Mobile phase modifier effects in multimodal cation exchange chromatography
RU2018121653A (ru) Улучшенное разделение белков при ионообменной хроматографии
JP2018516229A5 (OSRAM)
KR20220079910A (ko) 숙주-세포 단백질을 특성화하는 방법
Yang et al. Effect of cleaning agents and additives on Protein A ligand degradation and chromatography performance
US20170198008A1 (en) Methods and reagents for purification of proteins
Gjoka et al. Combined Protein A and size exclusion high performance liquid chromatography for the single-step measurement of mAb, aggregates and host cell proteins
Marek et al. Isolation of monoclonal antibody from a Chinese hamster ovary supernatant. I: Assessment of different separation concepts